Promotion of central nervous system remyelination by induced differentiation of oligodendrocyte precursor cells - Wikidata - wikimedia - TriplyDB

Promotion of central nervous system remyelination by induced differentiation of oligodendrocyte precursor cells

Promotion of central nervous system remyelination by induced differentiation of oligodendrocyte precursor cells

http://www.wikidata.org/entity/Q30051733

about

Oligodendrogenesis in the normal and pathological central nervous system Death receptor 6 negatively regulates oligodendrocyte survival, maturation and myelination Assembly of Neuronal Connectivity by Neurotrophic Factors and Leucine-Rich Repeat Proteins Regenerative Capacity of Macrophages for Remyelination Remyelination Therapy in Multiple Sclerosis Remyelination therapy for multiple sclerosis Applications of SPR for the characterization of molecules important in the pathogenesis and treatment of neurodegenerative diseases Promoting remyelination in multiple sclerosis-recent advances Improving the solubility of anti-LINGO-1 monoclonal antibody Li33 by isotype switching and targeted mutagenesis Identification of VHY/Dusp15 as a regulator of oligodendrocyte differentiation through a systematic genomics approach Neutralization of LINGO-1 during in vitro differentiation of neural stem cells results in proliferation of immature neurons Re-evaluating the treatment of acute optic neuritis.Recent developments in multiple sclerosis therapeutics Tapping into the glial reservoir: cells committed to remaining uncommitted.Importance of oligodendrocyte protection, BBB breakdown and inflammation for remyelination.Sonic hedgehog and neurotrophin-3 increase oligodendrocyte numbers and myelination after spinal cord injury.Lingo-1 expression is increased in essential tremor cerebellum and is present in the basket cell pinceau.Increased LINGO1 in the cerebellum of essential tremor patients.MicroRNAs: novel regulators of oligodendrocyte differentiation and potential therapeutic targets in demyelination-related diseases.LINGO-1, a transmembrane signaling protein, inhibits oligodendrocyte differentiation and myelination through intercellular self-interactions.Transcription factor-mediated reprogramming of fibroblasts to expandable, myelinogenic oligodendrocyte progenitor cells.Blocking LINGO-1 as a therapy to promote CNS repair: from concept to the clinic.Remyelination therapy goes to trial for multiple sclerosis Small-molecule Klotho enhancers as novel treatment of neurodegeneration.The potential of LINGO-1 as a therapeutic target for essential tremor.Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo.PDGF is required for remyelination-promoting IgM stimulation of oligodendrocyte progenitor cell proliferation.LINGO1 rs9652490 and rs11856808 polymorphisms are not associated with risk for multiple sclerosis.Reduced axonopathy and enhanced remyelination after chronic demyelination in fibroblast growth factor 2 (Fgf2)-null mice: differential detection with diffusion tensor imaging.Targeting the cis-dimerization of LINGO-1 with low MW compounds affects its downstream signalling Quercetin promotes proliferation and differentiation of oligodendrocyte precursor cells after oxygen/glucose deprivation-induced injury.Fingolimod modulates microglial activation to augment markers of remyelination.Mediators of oligodendrocyte differentiation during remyelination An organotypic slice culture model of chronic white matter injury with maturation arrest of oligodendrocyte progenitors.RhoA-inhibiting NSAIDs promote axonal myelination after spinal cord injury Emerging therapies for treatment of multiple sclerosis Fibroblast growth factor 1 (FGFR1) modulation regulates repair capacity of oligodendrocyte progenitor cells following chronic demyelination.Demyelination and remyelination in anatomically distinct regions of the corpus callosum following cuprizone intoxication Multifunctional, multichannel bridges that deliver neurotrophin encoding lentivirus for regeneration following spinal cord injury Cell therapy for multiple sclerosis.

P2860

Q21129352-030C79F5-788F-4008-BC9F-D2B1AC22C114 Q24310284-9831F86A-35CE-4DFF-A0FE-56A1454DC8BB Q26739532-6CE59646-5C7B-471B-9F7A-63943EC08A27 Q26744475-664AEB87-BC12-41C5-8447-AB9AA6AE978D Q26772359-E7263894-A22D-49D5-ADDF-B1C01A3C83A1 Q26824246-80ADD7DC-3669-4D7B-8A1D-F9525DB2B315 Q26860077-8DD7305D-916B-4F85-8711-E93D2FECF724 Q27010398-80713DC4-A303-4ED5-8A27-97D26966D829 Q27660092-D325E49A-E105-4B9B-B3AE-6CD7AFAA4280 Q28727258-2F6A409A-5DA9-4F9F-9961-79FCA5A64333 Q28740524-2BA90448-8BC7-49F0-B177-E4B2280F77D1 Q30865447-7044E7FD-AFE9-4010-A420-7A3A1D629665 Q30962193-704E9903-9B31-47B2-85E0-00D842B34BC7 Q33643732-708DCB09-F7D5-4841-A065-6F323499BB3A Q33740931-4EA96D6F-CDCE-4525-BB68-1AF9F39638BB Q33863348-9B5EF151-A35F-4404-B07A-58B7768E69D5 Q34036195-202F04A5-5B9C-40AE-801C-654DCCF3E6E9 Q34039911-3F7250EA-3D91-4C10-8AD7-56C216C561AB Q34244568-242BDEB3-0BA0-451E-8BBB-A78381B64459 Q34269251-F4986DC9-0A5E-4491-854A-55BAD2F82F23 Q34339127-148085F9-8C4B-4635-8D05-A8E39FE3C831 Q34345195-5E81AAF2-E9D8-49A3-80D8-809FD8271C57 Q34368564-EEA1514B-4FA8-4404-96B6-6C89DA64519C Q34394061-16CD4371-AB51-44EB-A15C-B214411C01B5 Q34471202-B32B419B-57F3-4548-841B-DE475B989D60 Q34472745-43B673C8-2136-43A3-A4D8-A17F09134D26 Q34577073-39A241DC-6F2B-407C-91BB-6BA66B062273 Q34662718-47945E82-48DD-4FC1-BE3F-7AFAAE5B9387 Q34769756-E87568F1-67E3-4A8D-81DD-9B3512C07000 Q34994532-08BB0C3F-17BB-4C2D-B708-03D130A7A10E Q35092454-3356CC9A-E4AC-4F23-B89B-487D01FD2BD6 Q35154946-C45969DA-D75B-4BDC-9AF5-9696E36A1B0C Q35173135-70B4F3A4-D580-4C60-B80F-3E5015FECAEF Q35185001-598C2841-B6B7-419B-AD99-48721B1C788E Q35209243-DF24040E-F7AE-47C9-B70A-2E205755ED68 Q35557390-4529315D-F114-461F-A41B-83F11AF7AE64 Q35577292-2BBE8A38-60A3-40EE-B1F8-0295A562CBEC Q35592803-D008A5C8-5933-4DE2-9D35-5CF1137C43DD Q35613352-E54817E0-42C7-4012-B5DD-86E400B0205F Q35648117-7F08DE58-0439-4303-B0CA-ECA8C328AA7A

P2860

Promotion of central nervous system remyelination by induced differentiation of oligodendrocyte precursor cells

http://www.wikidata.org/entity/Q30051733

description

2009 nî lūn-bûn

@nan

2009 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի մարտին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Promotion of central nervous s ...... ligodendrocyte precursor cells

@ast

Promotion of central nervous s ...... ligodendrocyte precursor cells

@en

type

label

Promotion of central nervous s ...... ligodendrocyte precursor cells

@ast

Promotion of central nervous s ...... ligodendrocyte precursor cells

@en

prefLabel

Promotion of central nervous s ...... ligodendrocyte precursor cells

@ast

Promotion of central nervous s ...... ligodendrocyte precursor cells

@en

P1433

Q30051733-440EB493-31DD-46C8-9312-486C941C06DE

P1476

Q30051733-B8636AC5-BEA8-4840-AFC1-4A3D8F0E7FF9

P2093

Q30051733-03AA7154-BCA1-4458-A925-5BAD4EA19D55

Q30051733-057AAA8B-E27C-47B1-BF6E-BAF47C0AB24E

Q30051733-16E1D5BB-2668-4230-8698-6AE2DD81AD13

Q30051733-1DCAACE9-3654-4EE2-A94D-B02A631BD768

Q30051733-2975B807-7322-4CCB-9E46-02E3DA74A84D

Q30051733-29CC3D4C-DADA-43B2-8030-15A5D8D4418F

Q30051733-31EE7226-8412-4D84-8304-391804D63729

Q30051733-483A07C8-5416-49B3-A300-FFFE2BFF0140

Q30051733-54E71504-6B26-4474-9C64-7DE038A3A8E5

Q30051733-6EF6E9CB-DD3B-4687-868B-35119F8F7346

P304

Q30051733-09AB7D01-234E-48E1-B3C3-8AA7FCDD40C7

P31

Q30051733-2FA5E2AB-A620-4ED1-9022-DCEA15A51C95

P3181

Q30051733-E1631818-ACEA-479E-8583-DC83381D4C90

P356

Q30051733-148B53B2-09AA-4AD1-8E3E-2B1B49C5220F

P433

Q30051733-BD07B08A-EE02-47EF-96D9-F0E1A05FB570

P478

Q30051733-41E93693-F204-43A4-B581-CE50052401A8

P50

Q30051733-1375A927-32AD-4A10-9310-4B21C5918947

Q30051733-FB0EBA1B-74C9-4408-8E94-487C775231A1

P577

Q30051733-53498C79-9FDD-4D13-964D-8E260A1BF488

P698

Q30051733-30291494-2258-45E2-A58B-699648786785

P921

Q30051733-7081C878-962C-49AB-9A23-31F280D7610C

P3181

P356

P1433

Annals of Neurology

P1476

Promotion of central nervous s ...... ligodendrocyte precursor cells

@en

P2093

Aude Roulois

http://www.w3.org/2001/XMLSchema#string

Benxiu Ji

http://www.w3.org/2001/XMLSchema#string

Bing Hu

http://www.w3.org/2001/XMLSchema#string

Blake Pepinsky

http://www.w3.org/2001/XMLSchema#string

Christopher B Shields

http://www.w3.org/2001/XMLSchema#string

Diana Shea

http://www.w3.org/2001/XMLSchema#string

Frederic Bernard

http://www.w3.org/2001/XMLSchema#string

Janfeng Xu

http://www.w3.org/2001/XMLSchema#string

Jeff Mason

http://www.w3.org/2001/XMLSchema#string

Robert H Miller

http://www.w3.org/2001/XMLSchema#string

P304

304-315

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

488514

http://www.w3.org/2001/XMLSchema#string

P356

10.1002/ANA.21581

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

65

http://www.w3.org/2001/XMLSchema#string

P50

Alain Chédotal

Robin J.M. Franklin

P577

2009-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19334062

http://www.w3.org/2001/XMLSchema#string

P921

oligodendrocyte